Dr. Jonas Lanz and Dr. Yazan Daaboul Discuss: Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis September 18, 2022 Disclosure: TBA
Dr. Renuka Jain and Dr. C. Michael Gibson Discuss: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates from the Intrepid Pilot Study September 18, 2022 Disclosure: TBA
Dr. Philippe Genereux Presents: Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results from the PARTNER Trials September 18, 2022 Disclosure: TBA
Dr. Santiago Garcia and Dr. C. Michael Gibson Discuss: Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data September 18, 2022 Disclosure: TBA
Dr. Deepak L. Bhatt and Dr. C. Michael Gibson Discuss: Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-year Follow-up of the SYMPLICITY HTN-3 Trial September 18, 2022 Disclosure: TBA
Dr. Ajay Kirtane Presents: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial September 18, 2022 Disclosure: TBA
Dr. Sanjit Jolly and Dr. C. Michael Gibson Discuss: Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) September 18, 2022 Disclosure: TBA
Dr. Shao-Ling Chen Presents: Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial September 18, 2022 Disclosure: TBA
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2022 Daily Wrap-Up – September 17 2022 September 17, 2022 Disclosure: TBA
Dr. Jason Rogers and Dr. Ralph Stephan von Bardeleben and Dr. C. Michael Gibson Discuss: Contemporary Clinical and Echocardiographic Outcomes of 1000+ Patients Treated With MitraClip™ G4: Results From the EXPAND G4 Post Approval Study September 17, 2022 Disclosures: TBA
